All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Lactic acidosis in patients with solid cancer

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F22%3A43923230" target="_blank" >RIV/00216208:11120/22:43923230 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1089/ars.2021.0267" target="_blank" >https://doi.org/10.1089/ars.2021.0267</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1089/ars.2021.0267" target="_blank" >10.1089/ars.2021.0267</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Lactic acidosis in patients with solid cancer

  • Original language description

    Significance Tissue-specific lactic acidosis in cancer stimulates and mediates tumor invasion and metastasis and is druggable. Rarely, malignancy causes systemic lactic acidosis, the role of which is poorly understood. Recent advances The understanding of the role of lactate has shifted dramatically since its discovery. Long recognized as only a waste product, lactate has become known as an alternative metabolism substrate and secreted nutrient that is exchanged between the tumor and the microenvironment. Tissue-specific lactic acidosis is targeted to improve the host body&apos;s anticancer defense and serves as a tool that allows the targeting of anticancer compounds. Systemic lactic acidosis is associated with poor survival. In patients with solid cancer, systemic lactic acidosis is associated with an extremely poor prognosis, as revealed by the analysis of 57 published cases in this study. Although it is considered a pathology worth treating, targeting systemic lactic acidosis in patients with solid cancer is usually inefficient. Critical issues Research gaps include simple questions, such as the unknown nuclear pH of the cancer cells and its effects on chemotherapy outcomes, pH sensitivity of glycosylation in cancer cells, in vivo mechanisms of response to acidosis in the absence of lactate, and overinterpretation of in vitro results that were obtained using cells that were not preadapted to acidic environments. Future directions Numerous metabolism-targeting anticancer compounds induce lactatemia, lactic acidosis or other types of acidosis. Their potential to induce acidic environments is largely overlooked, although these compounds might contribute to a substantial portion of the observed clinical effects.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Antioxidants &amp; Redox Signaling

  • ISSN

    1523-0864

  • e-ISSN

    1557-7716

  • Volume of the periodical

    37

  • Issue of the periodical within the volume

    16-18

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    23

  • Pages from-to

    1130-1152

  • UT code for WoS article

    000810230000001

  • EID of the result in the Scopus database

    2-s2.0-85138702256